Nancy Stuart, Chief Operating Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 6,049 shares at $7.32 ($44K) on 2021-02-16, disclosed to the SEC on 2021-02-17.
Scheduled sale ($44k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CNCE | SELL | 2023-01-09 | $21K | — | Filing → |
| CNCE | SELL | 2022-02-16 | $19K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |